AOGIN - Asia Oceania research organisation on Genital Infections and Neoplasia, India

Keynote, Chairpersons and Invited Speakers

Latest News

Keynote, Chairpersons and Invited Speakers

Keynote address: Beyond the Nobel Prize - Reducing the Burden of Cervical Cancer
	Keerti Shah is Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School in Baltimore, USA. He received his medical degree as well as training in virology in Pune, India. He participated in the early IARC studies which helped establish the link between HPV infection and cervical cancer and in studies that defined the role of HPVs in subsets of vulvar and oropharyngeal cancers and in the etiology of juvenile-onset respiratory papillomas. Beginning in 2000, with financial support from NIH
and the Dept of Biotechnology, Govt of India, Dr Patti Gravitt and Dr Shah collaborated with investigators in Medchal Mandal in Andhra Pradesh, AIIMS in New Delhi, and CMCH in Vellore in evaluation of screening strategies for cervical cancer.

Keynote address Chairpersons
	Jong Sup Park, President of AOGIN Professor and Director of Division Gynecologic Oncology, Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea,

Presidential Lecture Chairpersons
	Hextan Ngan

DR. (MS.) S. K. DAS MD, FICOG, FIAMS, FICMCH
	Head of the Department - Gynae Oncology B.L. Kapoor Memorial Hospital, Pusa Road, New Delhi
Former Sr. Consultant - Gynae Oncologist Sri Balaji Action Medical Institute, Paschim Vihar, Delhi. Bhagwan Mahavir Hospital, Rohini, Delhi. Former Consultant & Chief of Gynae Oncology Rajiv Gandhi Cancer Institute & Research Centre, Rohini, Delhi. Former Consultant and Head of the Department of Obst. & Gynae Safdarjung Hospital, Delhi. Residence Add. : B-202, Welcome Apartments, Sector-9, Rohini, Delhi-110 085. Contact Nos. : (M) 09810059380; (R) 011-27552151, (R) 011-47097554 Patron : Indian Association of Colposcopy Cervical Pathology & NARCHI, Delhi. Founder President : Association of Gynae Oncologist of India & NARCHI, Delhi. Ex-President & Life Member : AOGD & IMA, New Delhi Branch. Vice President : FOGSI, 1995. Member : International Association of Gynecological Cancer. Chairman : Sub Committee of Cervical Pathology and Colposcopy of Indian Academy of Cytologist. An excellent teacher and eminent Colposcopist. Deeply interested in Prevention of Gynae Cancer. Edited a slide atlas on Colposcopy, Cytology & Histopathology of Cervix. Written a book of Cytology, Colposcopy & Histopathology of lower genital tract. Contributed chapters in several reputed books, National & International Journals. Conducting regular courses of Cytology & Colposcopy across the country, 2-3 every year since 1984. Regularly participating, conducting camps and public meetings for awareness programme and early detection of cancer in females.

Plenary - Natural History and Epidemiology
	Jeffrey Tan graduated in medicine from University of Melbourne, Australia and did his postgraduate training at the Royal Women's Hospital, Melbourne. He became a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists in 1986. He is a consultant Gynaecologist in the Oncology and Dysplasia Unit at the Royal Women's Hospital. He is involved in clinical research on HPV and in HPV Vaccine trials. Current positions include Permanent Secretary of Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN),
Chairperson of IT committee of International Federation for Cervical Pathology and Colposcopy (IFCPC) and Member of Asian Cervical Cancer Prevention Advisory Board (ACCPAB).

Plenary - Natural History and Epidemiology The natural history of cervical neoplasia: applications in early detection & prevention
	R. Sankaranarayanan is currently Head of the Section of Early Detection and Prevention and of the Screening Group at the International Agency for Research on Cancer of the World Health Organization in Lyon, France. His major interests include early detection of cancer and cancer control, particularly in less developed countries. He has more than 150 publications in international peer-reviewed journals and has authored widely acclaimed manuals on early detection of cervical cancer which have been translated into several languages including Chinese, French, Hindi, Portuguese, Spanish, and Turkish among others.

Plenary - Natural History and Epidemiology Global HPV epidemiology update:
	F. Xavier Bosch conducts epidemiological research on cancers linked to infectious agents notably on cancer of the liver, of the cervix, of the skin, of the vagina, of the anus, of the penis and of the oral cavity. He has also carried on research studies on diet and colorectal cancer and lead a program of implementation and methodological research in cancer registration. These various research projects have been instrumental in demonstrating the causal role of Human Papilloma Virus (HPV) in cervical cancer and on the opportunities for liver cancer prevention using Hepatitis B Virus (HBV) vaccines in rural Africa. Some of these studies have played a catalytic role for the initiation of the first vaccine trials for HBV and HPV and for the evaluation of HPV tests as screening tools. Dr. F. Xavier Bosch has worked in what is now called molecular
epidemiology. His research work has been characterized by the integration of the latest biological assays to determine exposure to carcinogens with epidemiological field studies carried out in about 35 countries around the world, particularly in Spain, Latin America, Africa and Asia. The final goal of his research has been the application of the aetiological knowledge derived from it, to the primary prevention of cancer.

Plenary - Natural History and Epidemiology Asia Oceania HPV Update
	Ji-Hong Liu obtained her MD and Master degree from the Sun Yat-sen University of Medical Sciences, China in 1984 and 1993, respectively. She then graduated from the University of Sydney, Australia with a PhD degree in 2004. After completing her internship training, Dr. Liu has been a practicing gynaecologist in the Cancer Center of Sun Yat-sen University for 20 years. In her general practice, she
participated in clinical and translational research. She has lectured extensively throughout the country on gynaecologic oncology and published more than 50scientific articles. During 2004 to 2008, she had been in charge of the administration of science research and the establishment of medical information system in the hospital as a vice-president of the Cancer Center,

Plenary - Natural History and Epidemiology Male genital HPV infections
	Suzanne M Garland

Plenary - Eradication of Cervical Cancer: New Horizons Chairperson
	Keerti Shah is Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School in Baltimore, USA. He received his medical degree as well as training in virology in Pune, India. He participated in the early IARC studies which helped establish the link between HPV infection and cervical cancer and in studies that defined the role of HPVs in subsets of vulvar and oropharyngeal cancers and in the
etiology of juvenile-onset respiratory papillomas. Beginning in 2000, with financial support from NIH and the Dept of Biotechnology, Govt of India, Dr Patti Gravitt and Dr Shah collaborated with investigators in Medchal Mandal in Andhra Pradesh, AIIMS in New Delhi, and CMCH in Vellore in evaluation of screening strategies for cervical cancer.

Plenary - Eradication of Cervical Cancer: New Horizons Novel cellular/molecular mechanisms of HPV infections & cervical carcinogenesis - Role of epigenetics
	Sharmila Sengupta, Associate Professor, Human Genetics Unit, Indian statistical Institute, 203, B.T. Road, Kolkata-700108.
Research Interest:
Natural history of HPV infection Secondary determinants (cofactors) for HPV persistence and disease progression Host genetic and epigenetic factors that may influence cervical cancer pathogenesis with special emphasis on cell cycle regulatory pathway, immunogenetic factors (HLAs) and folate metabolic pathway Viral (HPV) factors such as genetic and epigenetic changes that may influence cervical cancer pathogenesis Biomarkers development for efficient diagnosis of cervical cancer including genomics / proteomics of various pathological stages of cervical cancer HPV vaccines
Plenary - Eradication of Cervical Cancer: New Horizons Sequence variation within HPV16 isolates implicated in cervical cancer pathogenesis
	Dr. Neeta Singh, Professor, Dept. of Biochemistry, AIIMS, New Delhi, India. She received her Ph.D. in Biochemistry in 1976 from Delhi University, India. In 1979 she served a post doctoral fellowship at Neurochemical Institute, Denmark and in 1983 at Swiss Institute for Experimental Cancer Research, Switzerland. In 1992 she was a visiting associate at National Cancer Institute, USA. She was awarded Danish Govt. Fellowship (DANIDA), Swiss Govt. Fellowship, ICRETT award of International Union Against Cancer (UICC) in 1989 and 1997, UNDP award, Universitat / Witten award, Visiting associateship of NIH Fogarty, USA, membership of National Academy of Medical Sciences, India, International Union against Cancer (UICC), American
Association for Cancer Research, New York Academy of Sciences. She has attracted funds from various funding agencies in India - ICMR, CSIR, DST, DBT, Ministry of Health for 21 Research Projects. During her career spanning 33 years she has had varied organizational, teaching and research experience. She has been supervision / co-supervisior for 23 Ph.D., 12 M.D. and 7 M.Sc. students. She has nearly 146 research publications to her credit. She has distinguished herself in the field of cancer research and has made a significant contribution in understanding chemical carcinogenesis, ROS and signal transduction mechanisms, role of telomeres, telomerase, and HPV in cancer, impact of apoptosis in health and disease (cancer), and experimental cancer therapeutics and prevention and chemoprevention.

Plenary - Eradication of Cervical Cancer: New Horizons Second generation vaccines - a suitable alternative?
	Dr. Mausumi Bharadwaj, Ph.D Currently she is Assistant Director (Scientist D) in Institute of Cytology and Preventive Oncology (ICMR), Noida. Obtained her Ph.D from Indian Institute of Chemical Biology, Calcutta. After her post-doctoral fellowship in Chicago Medical School, USA, she joined as Res. Assistant Professor in Department of Infectious Disease in UNM School of Medicine, Albuquerque, USA. She is member of several societies including HUGO, London. Her current research interest is Genetics & Epigenetics of cervical cancer and Second Generation vaccines against Human papillomavirus (HPV).

Plenary - Eradication of Cervical Cancer: New Horizons Natural antivirus & immunomodulators
	Dr. Bhudev C. Das, Professor of Biomedical Sciences, Ambedkar Center for Biomedical Research, University of Delhi and formerly Founder Director, Institute of Cytology and Preventive Oncology (ICPO) of ICMR, Noida.has made outstanding contributions in the field of Cancer Research, Tumor Virology and Genetics. During last 30 years of his distinguished research career he has published 135 research papers in reputed international journals and distinguished himself as a renowned molecular oncologist of the country. Dr. Das who worked several years with 2008 Nobel Prize (Medicine) winner, Prof. Harald zurHausen has pioneered the work on Human
Papillomavirus (HPV) in India. His laboratory is the National and WHO HPV Referral Centre in South-East Asia and his major areas of research interest are transcriptional regulation of viral oncogene expression, HPV DNA vaccine and stem cell research. So far 16 Ph.D. and 62 MD/MS/DM/DNB students have received their degrees under his supervision and guidance. Dr. Das is the recipient of President's medal for most prestigious Dr. B.C. Roy National Award of MCI, Sandoz Oration Award of ICMR and a Fellow of International Union Against Cancer (UICC), Geneva. He is Fellow of all major national science and medical academies, FNA, FASc, FNASc and FAMS. Dr. Das is elected President of Indian Association for Cancer Research (IACR) for 3 years (2006-2009). He is a PI and an expert advisor of the Global HPV LabNet and Vaccine Program of WHO, Geneva. Dr. Das has received several other prestigious awards e.g., Ranbaxy Research Award, Dr. P.N. Wahi Award of ICMR, Ramniklal J. Kinarival Cancer Research Award of Gujarat Cancer Research Institute, Ahmedabad, Dr. Pran Nath Chhuttani Oration Award of National Academy of Medical Sciences (NAMS), New Delhi. Recently, he has been awarded the most prestigious J.C. Bose National Fellowship.

Plenary - Eradication of Cervical Cancer: New Horizons HPV and progression to cancer in the immunosuppressed
	Professor Priya Abraham currently heads the department of Clinical Virology, at Christian Medical College, Vellore, a 2234 bedded multi-specialty tertiary care hospital.In the field of human papilloma viruses, she has investigated the role of HPV PCR in screening for cervical cancer in a DBT-NIH funded study. Subsequently she was funded to study the role of HPV markers in prognosis of cervical cancer and also the molecular epidemiology of HPV in India and its variants. She is part of the Indian HPV working group. She is currently working on HPV infection in HIV seropositive
MSMs (ICMR-NIH) and will be starting work on HPV in head and neck tumours in collaboration with McGill University Canada and Albert Einstein College, New York. She is a Fellow of the Royal Society of Tropical Medicine and Hygiene. She has served as a consultant for the Population Council and for the "Sthree Arogya Shodh" (funded by the London School of Tropical Medicine and Hygiene and Directorate of Health at Goa).

Plenary - Screening of Cervical Neoplasia Chairperson
	Albert Singer

Plenary - Screening of Cervical Neoplasia START - UP program results
	Jose A. Jeronimo currently acts as the project director for the Screening Technologies to Advance Rapid Testing for Cervical Cancer Prevention-Utility and Program Planning (START-UP) project at PATH in Seattle, WA. He brings with him a long list of professional honors, specialty training, book and journal publications, as well as extensive teaching and scientific leadership experience. Jose received his MD in Peru in 1989, but since then has gone onto receive specialty training in gynecologic oncology in the National Cancer Institute in Peru. Most recently, he served as the staff scientist for the Division of Cancer Epidemiology and Genetics within the NCI/NIH Human Papillomavirus Unit of the Hormonal and Reproductive Epidemiology Branch for 6 years. He is reviewer in several specialized peer-reviewed journals such as American
Journal of Obstetrics & Gynecology, Journal of Lower Genital Tract Disease, Journal of the National Cancer Institute and Obstetrics and Gynecology. He was honored with the Meritorious Award of Scientific Achievement by the American Society for Colposcopy and Cervical Pathology where he serves as member of the Committee on Research, Assessment Committee and the AD-HOC Subcommittee on Patient Education.

Plenary - Screening of Cervical Neoplasia Self-sampling - A viable alternative?
	Neerja Bhatla, M.B.B.S, M.D, is Additional Professor in the Department of Obstetrics & Gynaecology at the All India Institute of Medical Sciences, New Delhi. She is a graduate and postgraduate of this prestigious medical school and has been on the Faculty since 1989. She is also an Adjunct Faculty Member of the Clinical Epidemiology Unit at AIIMS, which is an affiliate of the International Clinical Epidemiology Network (INCLEN). Dr. Bhatla has successfully undertaken numerous research projects in India on cervical cancer screening in low resource situations, HPV epidemiology, a trial of the rapid, affordable test and HPV vaccine trials. She has been the recipient of a UICC Fellowship at the University of Cape Town on the subject of
Community-based Screening Programs and has worked in collaboration with the International Agency for Research on Cancer (IARC), Lyon, France and the Johns Hopkins Bloomberg School of Public Health, USA. She has been a member of several committees on issues of cervical cancer prevention. She has published over 90 papers in national and international journals, has contributed to FIGO guidelines, written chapters in books and monographs and edited a Textbook of Gynaecology. She is also on the review boards of several scientific journals. She is Vice President of the Asia Oceania research organization on Genital Infections and Neoplasia (AOGIN) and the Founder President of AOGIN-India.

Proffered Papers I Basic Sciences: New Techniques and Molecular Markers Chairperson
	Annie Cheung, Current Position: Clinical Professor, The University of Hong Kong, Honorary Consultant, Queen Mary Hospital, Honorary Professor, Department of Obstetrics and Gynaecology, The University of Hong Kong, Director of Cervical Cytology Screening Laboratory and University pathology Laboratory (Molecular Pathology), The University of Hong Kong Vice President and Chairman, Training and Examination Committee, Hong Kong College of Pathologists.
Qualifications: M.B.B.S. (HK); M.R.C. Path (UK); F.H.K.A.M. (HK); F.R.C.Path (UK); F.I.A.C; M.D. (HK); Visiting / Honorary Professorship Edward Rotan Visiting Professor at the University of Texas, MD Anderson Cancer Centre, Honorary Professor, First Clinical Medical College of Zhengzhou University, China, Honorary Professor, Harbin Medical University, Honorary Professor, University of Arizona, Tuscan, USA, Honorary Professor & Medical Consultant, International Peace Maternity and Child, Health Hospital, JiaTong University, Shanghai. Awards: Sir Patrick Manson Gold Medal for outstanding M.D. Thesis, Best Practice Care for Gynae-Oncology Patients and Families Team, Hong Kong West Cluster Outstanding Teams Award and the Certificate of Merit in Hospital Authority Outstanding Teams Award competition for Quality Assurance in Cytology, University Teaching Fellow, Award for Innovative Excellence in Teaching, Learning & Technology (17th International Conference on College Teaching and Learning, Hong Kong West Cluster and Queen Mary Hospital Outstanding Teams Award 2009 for "Gynae-Oncology Team, QMH" Prizes awarded to postgraduate students: International Scholar-in-Training Awards by the American Association for Cancer Research (AACR) for MPhil and PhD students and Postdoctoral Fellow [2003-2008]. Main Areas of Research: The main fields of my research focus on gynaecological pathology focusing on biological and genetic studies of gynaecological cancers and application of advanced techniques in laboratory medicine such as cervical cytology. More than 200 publications in international peer reviewed journals, book chapters and invited review articles have been published. I have served as reviewer for international journals. My research has been supported by internal and external bid research funding.

Plenary - New issues on HPV Vaccination Current evidence from prophylactic vaccines- Are we confused?
	E H Tay

Plenary - AOGIN Education Session CIN 1: When should it be treated?
	Shalini Rajaram is a Professor of Obstetrics and Gynecology at the Her area of interest is Gynecologic Oncology especially the field of cancer of the cervix. She has worked extensively on neoadjuvant chemotherapy in locally advanced cervical cancer and has won the 'Young Scientist's' award by the Association of Gynecologic Oncologists of India (1999), the President's prize of the Japan Society of Obstetrics and Gynecology (2004) for work in cancer cervix and was awarded travel scholarship by IGCS in 2008. She has several publications in both National and International journals and has authored 7 books. She is well known for her academic skills as writer, speaker, author and is on the editorial board of three Indian journals. She is presently working on promoting visual based tests as extended gynecological examination

Plenary - Eradication of Cervical Cancer: New Horizons New molecular markers in prediction of high grade disease
	Dr. Sandeep R Mathur, MD Designation: Assistant Professor, Department of Pathology Areas of Interest: Gynaecologic Pathology Cytopathology Breast Pathology He has many publications in international & national journals of repute. He has many on-going projects in his fields of interest. He aims at providing excellence & state of the art diagnosis especially in the field of women healthcare.
Address for correspondence: Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029. India Tel Nos: Office: 91 11 2658 8700 Ext 4393 Residence: 91 11 26101424, 91 11 2658 8700 Ext 3228 Mobile: 09868437659, 09868397198 Plenary Session - Management of cervical neoplasia HPV positive test: What do you do? Efren J. Domingo, M.D.,Ph.D. Medical and Doctoral Degrees: Doctor of Medicine, UP College of Medicine, Class 1982 Doctor of Philosophy, Hormone Receptor Studies in Endometrial Cancer, Kyoto PrefecturalUniversity of Medicine, Kyoto, Japan, 1995 Academic Rank and Academic/Clinical Appointment: Professor VI, UP College of Medicine, Department of Obstetrics and Gynecology Active Consultant, Philippine General Hospital, Department of Obstetrics and Gynecology Vice Chair for Academic Affairs, Department of Obstetrics and Gynecology, UPCM-PGH Chief of Section, Department of Obstetric and Gynecology, Section of Gynecologic Oncology Positions in Professional/Scientific Organizations (Philippines) President, Society of Gynecologic Oncologists of the Philippines, 2005, 2006, 2007. President, Asia Oceania Research Organization in Genital Infection and Neoplasia, Philippine Chapter,2008, 2009, 2010. President, Asia Oceania Research Organization in Genital Infection and Neoplasia, Philippine Chapter, 2008, 2009. Treasurer, Philippine Society of Cervical Pathology and Colposcopy, 2005, 2006, 2007 Member of The Finance Committee, The Philippine Obstetrical and Gynecological Society Member of The Credentials Committee, The Philippine Obstetrical and Gynecological Society Positions in Professional/Scientific Organizations (International) Secretary General, Asia Oceania Research Organization in Genital Infection and Neoplasia, (AOGIN) 2008, 2009, 2010. Editorial Board Member, The International Journal of Gynecologic Cancer, 2005, 2006, 2007, 2008 Chairman of The Asian Gynecologic Oncology Group, 2004, 2005 Education Committee Member, The Internal Gynecologic Cancer Society, 2005, 2006, 2007 Board of Director, Asia Oceania Research Organization in Genital Infection and Neoplasia, 2005, 2006, 2007 Member of the Cancer Committee of The Asia Oceania Federation of Obstetrics and Gynecology, 2008. Awards/Recognition Received Most Outstanding Researcher in Gynecologic Oncology, Awarded by the Philippine Society of Gynecologic Oncology, 2005 PSO Annual Convention, Edsa Shangrila, October, 2005 Positions Held in Specialty Society Examination Board Secretary, Philippine Board of Obstertrics and Gynecology, 2006, 2007, 2008. Board Examiner, Philippine Board of Obstetrics and Gynecology, 2005. Board Examiner, Philippine Board of Surgery, 2008. Plenary Lectures, (International) The FIGO World Congress, Kuala Lumpur, Malaysia, Nov. 2006. "Hormones and Endometrial Cancer." The Third Euro Asian Congress of Obstetrics and Gynecology, St Petersburg, May, 2005. "Chemoradiation Using Ifosfamide for Locally Advanced Cervical Cancer" The Second Biennial Meeting of the Asia Oceania Research Organization in Genital Infection and Neoplasia, Cebu City, Philippines, Sept. 2006. " Management of Cervical Intraepithelial Neoplasia" The 2006 Biennial Meeting of the Inernational Gynecologic Cancer Society, Sta. Monica, California, October, 2006. "The Management of the Periaorta in Locally Advanced Cervical Cancer". Plenary Lectures (Philippines) 2005 Annual Convention of the Philippine Obstetrical and Gynecological Society, Inc. "The Management of the Cervical Intraepithelial Neoplasia III", Nov. 2005, PICC. 2007 Annual Convention of the Philippine Obstetrical and Gynecological Society, Inc., "The Role of the Quadrivalent HPV Vaccine in the Prevention of Cervical Cancer. Nov. 2007, PICC. 2006 Society of Adolescent Medicine Philippines Annual Convention, 'The Human Papillomavirus Vaccine in the Prevention of Cervical Cancer. Century Park Sheraton Hotel, Sept. 2006. 2007 Philippine Society of Medical Oncology, "The Control of Cervical Cancer Using the HPV Quadrivalent Vaccine", Edsa Shangrila Hotel, October, 2007. 2007 Annual Convention of the Society of Medical Technologists of the Philippines, 'The Humanpapilloma Virus Vaccine and the Control of Cervical Cancer". Century Park Sheraton Hotel, May, 2007. 2005 Mid Year Convention of the Society of Gynecologic Oncologists of the Philippines, " The Nerve Sparing Radical Hysterectomy for Early Stage Cervical Cancer", Linden Suites, May, 2005. Advisory Board Membership (International) The Cervical Cancer Prevention in Asia Advisory Board, Merck Sharp and Dohme, 2005,2006,2007,2008. Asian Cervical Cancer Prevention Advisory Board , Glaxo Smith Kline, 2005, 2006, 2007, 2008. Multicenter-International Research Studies Participated Principal Investigator, The FUTURE III Study of the HPV Quadrivalent Vaccine in the Prevention of Cervical Cancer, Protocol V19, Merck Sharp and Dohme, Study Site: Manila Doctors Hospital, 2004, 2005, 2006, 2007, 2008, 2009. Principal Investigator, The Capecitabine Chemoradiation in Locally Advanced Cervical Cancer, Roche Company Inc., Study Site UPCM-PGH Section of Gyne Oncology, 2005,2006,2007,2008. Principal Investigator, The Ifosfamide Chemoradiation In Locally Advanced Cervical Cancer, Baxter Pharmaceutical Inc., Study Site, UPCM-PGH Section of Gyne Oncology, 2005, 2006. Authorship/Editorship of Manuals/Books (Philippines) Editor-in-Chief, The Clinical Practice Guidelines for the Gynecologic Oncologists, Fourth Edition, October, 2005, Published by the Society of Gynecologic Oncologists of the Philippines, Inc. Editor-in-Chief, The Clinical Practice Guidelines in Gynecologic Oncology for the Obstetrician-Gynecologists, First Edition, October, 2005, Published by the Society of Gynecologic Oncologists of the Philippines, Inc. Authorship/Editorship of Manuals/Books (International) Lead Author, The HPV Monograph, A Supplement of the Journal "Vaccine". "The Prevention of Cervical Cancer in Indonesia, Malaysia, Philippines, Thailand and Vietnam". Co authors: T Van Thuan, K Limphapayom, 2008. In Press. Chairmanship in Hosting of An International Scientific Meeting/Convention Overall Chair, The Second Biennial Congress of the Asia Oceania Research Organization in Genital Infection and Neoplasia (AOGIN), Shangrila Mactan, Cebu City, Sept 7,8,9, 2006.

Plenary Session - Management of cervical neoplasia CIN management options and post-treatment follow-up
	Patrick Walker, MD FRCOG, Consultant Gynaecologist at the Royal Free Hospital, London, UK, Past President of the British Society of Colposcopy and Cervical Pathology (BSCCP) Current President of the International Federation for Cervical Pathology and Colposcopy (IFCPC)Member of the HPV special Interest Group of the English National Health Service Cervical Screening Programme (NHSCSP) Convenor of the Gynaecological Visiting Society of Great Britain and Ireland. Author of Original articles, chapters in text books and editorials on the aetiology, diagnosis and treatment of intraepithelial neoplasia of the lower genital tract.

Plenary Session - Management of cervical neoplasia Long term complications of cryotherapy and LEEP
	Quek Swee Chong is Senior Consultant and Head, Pre-invasive Disease and Screening Unit, Department of Gynaecological Oncology, KK Women's and Children's Hospital. He serves on the board of the International Federation of Colposcopy and Cervical Pathology. A former president of the Society of Colposcopy and Cervical Pathology of Singapore, he now sits on the present council. His special interest is in the area of prevention of gynaecological cancers, particularly cancer of the cervix.
He has a passion for teaching and training doctors and healthcare workers in under-privileged areas and has volunteered his services to the International Agency for Research into Cancer (IARC, WHO) to train many doctors in Thailand, Vietnam, China, Africa and India. He has authored several books and book chapters including "Lower Genital Precancer (Blackwell Science) and is presently working on another book on cervical cancer prevention .His research work includes real-time detection of cervical cancer and precancer, pap smear screening, HPV testing, and was involved in the clinical trials for HPV vaccines for the prevention of cervical cancer. He has given over 250 lectures, both regionally and internationally in the area of cervical cancer prevention and runs several training courses a year in colposcopy - an examination technique to identify and treat cervical precancer lesions.

Proffered Papers II- HPV Prophylactic Vaccines: Basic and clinical, aspects Chairperson
	Indrani Ganguli M.B.B.S. (Cal), M.D. (A.I.I.M.S.), FICMCH, FICOG
Chairperson & HOD Dept. of Obstetrics and Gynaecology of Sir Ganga Ram Hospital, New Delhi. Governing council member of ICOG (FOGSI) (2009-2011). Vice President NARCHI (All India). President AOGD 2008-09 Executive Member of Board of the Management, SGRH, Executive Member of the AOGD Past president NARCHI, Delhi Branch Past Member of Geriatric, FOGSI. Member of CME committee FOGSI Member of International Exchange Programme Committee FOGSI Past Secretory Indian Menopause Society, Delhi Branch (2006-2008) Life Member of Federation of Obstetrics & Gynaecology Societies of India. Life Member of the Indian Medical Association. Life Member of Indian Society of Oncology. Life Member of the Indian Association of Gynaecological Endoscopists. Life Member of AOGD. Life Member of ICMCH. Life Member of National Association of Reproductive & Child Health (NARCHI) Life Member of Indian Menopause Society (IMS) Life member ISOPERB Member Of International Menopause Society Life member of AGOICON In over 40 years of her career as a doctor, she has earned a name as an eminent practising Obstetrician & Gynaecologist, a competent teacher, a research guide and a research worker. She has more than 25 years of teaching experience. Her regularly published lucid papers, incorporating the latest developments in the field of Obstet. & Gynae are widely acclaimed. She has presented many papers at the state & national level and won first prizes for best papers award in FOGSI. She has also won first prize in debate in AOGD and Smt Bhagawato Devi yamuna Singh P award for Paper presentation in 51st AICOG 2008 On Doctors' Day 2006, the Delhi Medical Association conferred on her a commendation certificate fro contribution towards development of speciality and recognition of humanitarian approaches in day to day practice. Colposcopy, Oncology, Endoscopic Surgery, Geriatric Medicine, HighRisk Pregnancies are of special interest to her.

Plenary Session- Cancer Treatment updates Management of early stage cervical cancer - Outcomes of surgery and radiotherapy
	Lynette Denny is a Principal Specialist and Full Professor of Obstetrics and Gynaecology and is a registered sub-specialist in Gynaecological Oncology at Groote Schuur Hospital and University of Cape Town. She is also a full member of the Institute of Infectious Diseases and Molecular Medicine at University of Cape Town. Her research interest for the past 15 years has been in preventing cervical cancer in low resource settings and she has been published widely on the subject.
She was awarded the Distinguished Scientist for Improving the Quality of Life of Women by the South African Department of Science and Technology in 2006 and is a rated scientist by the National Research Foundation of South Africa.

Plenary Session- Cancer Treatment updates Surgical Management of FIGO IB2 and IIB Cervical Cancer
	Shingo Fujii after graduating in Medicine at Kyoto University 1971, he worked as a clinician for 6 years and then received a PhD at Kyoto University in 1981. After the work as the assistant professor and associate professor of the Department of Gynecology and Obstetrics at Kyoto University, he was appointed as a Professor and Chairman of the Department of Obstetrics and Gynecology at Shinshu University. In 1997, he returned to Kyoto University as a Professor and Chairman of the Department of Gynecology and Obstetrics served as the Chairman until 2007.
Then he was appointed as President of the National Hospital Organization Kyoto Medical Center, and he is doing both clinical work and the management of the hospital since 2007.His main research contributions have been in the understanding of pathogenesis of smooth muscle tumor in the uterus, cervical cancer, endometrial cancer and ovarian cancer. As the successor of Okabayashi's radical hysterectomy that was established at Kyoto University, he accomplished the meticulous anatomy for Okabayashi's method, which enabled him to operate on the surgery with the minimum amount of blood loss and preservation of nerve function to the urinary bladder. He has been involved in education, research, and clinics, and published more than 300 English papers in the peer review journals. He was elected as President of the Japan Society of Obstetrics and Gynecology (JSOG) in 2004. He was elected Honorary Fellow of The American College of Obstetricians and Gynecologists and The Society of Obstetricians and Gynecologists of Canada in 2005, and Honorary Fellow of The Japan Society of Obstetrics and Gynecology and The Korean Society of Obstetrics and Gynecology in 2007. He was elected as President-elect of the International Gynecologic Cancer Society (IGCS) in 2008 and from the IGCS meeting in Prague 2010 his Presidency period for 2 years will start. He has been a Professor Emeritus at Kyoto University since 2007.

Plenary Session- Cancer Treatment updates Minimally Invasive Surgery in Gynaecologic Oncology
	Alka Kriplani is working as Professor in the Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi. She has been invited by Royal College of Obstetricians and Gynaecologists, London for award of Fellowship ed eundem; Honorary FRCOG degree which is a rare honor awarded to only a few in recognition of major contributions made to the advancement of the science or practice of Obstetrics and Gynaecology. She is also the recipient of Dr B C Roy National Award for the year 2007 in recognition of services as "Eminent Medical Teacher" by the President of India.
She is the Editor of Asian Journal of Obstetrics and Gynaecology practice for more than one decade. She is actively associated and occupies official positions with various national and international associations including FOGSI (Federation of Obstetricians and Gynaecologists of India). Presently she is "Vice President for the year 2009" of FOGSI. She is also the elected member of Governing Council of ICOG (Indian College of Obstetricians and Gynaecologists) and IAGE (Indian Association of Gynaecological Endoscopists).She has the honour of delivering 408 guest lectures all over India and abroad on various clinical subjects. She has contributed more than 269 scientific publications and 271 Abstract Publications in national and international journals. She has written 2 Books and contributed 53 Chapters in other books. She is recipient of many awards and honors conferred by various national and professional bodies for distinguished research, teaching and clinical work. This includes Rashtriya Gaurav Award 2007, DMA Medical teacher's award 2005 and prestigious Dr B C Roy National Award for the year 2007 for her services as "Eminent Medical Teacher" by the President of India.She is also the recipient of various awards including C L Jhaveri (FOGSI 1995), K P Tamaskar award (FOGSI 2002), Dr Neera Agarwal Gold Medal (AOGD 1999), Jagadishwari Mishra award (FOGSI 2006), Bayer Schering APCOC Talents Encouragement Award (Asia-Pacific Council on Contraception 2008), Dr. Nimish Shelat Research Prize in Reproductive Endocrinology (FOGSI 2010) for outstanding clinical research work. Her field of work is Reproductive Endocrinology and Gynaecological Endoscopy. She is regularly running an endoscopy training programme at AIIMS.

Plenary Session- Cancer Treatment updates The place of chemotherapy in cervical cancer
	Dr. Lalit Dar is an Additional Professor in the Virology Section of the Department of Microbiology, All India Institute of Medical Sciences (AIIMS), New Delhi. After completing his MBBS from the Maulana Azad Medical College, Delhi University, he acquired his MD degree in Microbiology from AIIMS. He has been working as a faculty member in the Virology Section since 1994. Apart from virology, he is well-versed in molecular biology and immunology. His major areas of interest are the viruses that affect maternal and child health, as well as arthropod- borne viruses.
He has completed various projects in these areas, with extramural funding from ICMR, DBT and NACO. Dr. Dar has more than 50 publications in national and international journals. He is a recipient of the Fogarty Fellowship of the National Institutes of Health (NIH), USA. He has long-term ongoing collaborations with the Department of Obstetrics and Gynaecology at AIIMS on human papillomavirus and with the University of Alabama at Birmingham (UAB), USA, on cytomegaloviruses. He has also been working actively on dengue virus infection. He has been a technical expert and consultant for the communicable diseases and molecular biology related activities of the International Atomic Energy Agency (IAEA), United Nations, on various occasions, since nearly a decade.

IARC Symposium - Promising Strategies for Cervical Cancer Programs in Low Resource Countries Chairperson
	Martha Jacob, FRCOG, MPH, has worked at PATH since 2007 and currently leads PATH's cervical cancer prevention work in India - HPV Vaccine: Evidence for Impact Project & START UP Project - designing and implementing formative studies, demonstration projects, strengthening secondary prevention activities and advocating for cervical cancer prevention. Dr. Jacob is an expert in the clinical and public health aspects of cervical cancer prevention having worked on this health issue both as a clinician and public health specialist in several developed and developing countries.
Dr Jacob graduated from Madurai Medical College, Madurai University, Madurai in 1978 following which she obtained her DGO also from Madurai University in 1980. She then trained in the UK and obtained membership to the Royal College of Obstetricians & Gynecologists (RCOG) in 1988 and was elected as fellow of the RCOG in 2001. Dr Jacob got her MPH degree from Columbia University, New York in 1998. Since 1998 her focus has been on the public aspects of reproductive health having worked as Regional Medical Advisor for Asia at EngenderHealth, specialist advisor to several WHO, UNFPA and Columbia University Programs and projects related to cervical cancer prevention, maternal care and other reproductive health care. Dr. Jacob has published several papers in peer-reviewed journals and contributed to several reports and manuals

IARC Symposium - Promising Strategies for Cervical Cancer Programs in Low Resource Countries Results of Cervical Cancer Prevention Programs and SVA in Thailand
	Wachara Eamratsameekool Education 1988 Doctor of Medicine, Chulalongkorn University, Thailand 1995 Certification in Obstetrics and Gynecology, Chulalongkorn University, Thailand 2001 Advanced Training Skills, JHPIEGO and Cervical Cancer Prevention Program, Thailand
Professional Experience Director; Mueywadi, Atsamat and Ponsai Hospitals, Roi Et, Thailand Obstetrician and Gynecologist, Phanomphrai Hospital, Thailand Director, Research and Development Office, Provincial Health Office, Roi Et, Thailand Publications and Dissemination Pelvic examination in ANC clinic: a rural hospital experience. Thai J Obstet Gynaecol 1998; 10: 209-12. Knowledge, attitudes and behaviors around cervical cancer among women enrolled in VIA SAFE demonstration project. Presented as oral communication to 15th Annual scientific meeting of the Royal Thai College of Obstetricians and Gynaecologists. October 17th-20th, 2000; Dusit Island Resort Hotel, Chiangrai. Maternal age figuration at Roi Et (1998-1999). Presented as oral communication to 15th Annual scientific meeting of the Royal Thai College of Obstetricians and Gynaecologists. October 17th-20th, 2000; Dusit Island Resort Hotel, Chiangrai. Sexual knowledge, attitude and behavior of primary and secondary education school students. A study report supported by Health System Research Institute, 2000. 111 pages. Maternal age figuration at Phanomphrai hospital, Roi Et (1998-1999). Med J Ubon Hosp 2000; 21:79-87. Premarital counseling clinic at Phanomphrai, Roi Et: a rural hospital initiation. Presented as oral communication to 16th Annual scientific meeting of the Royal Thai College of Obstetricians and Gynaecologists. October16th-19th, 2001; Bangkok. Sexuality education via computer-aided instruction for early secondary school students. Presented to 16th World Congress of Sexology, World Association for Sexology, on March 13th, 2003 at International Conference Center of Havana, Cuba. From Project to Programme: Key efforts for integrating VIA technique to comprehensive cervical cancer control programme in Roi Et. Awarded as outstanding oral presentation in MOPH annual scientific meeting 2003. Udomprasergul V, Supornsilpchai C, Suriyavanagul R, Eamratsameekool W. Health system development for chronic diseases under the universal coverage scheme: a case study of diabetes and hypertension. Bangkok: Institute of Health Research, Chulalongkorn University, May 2006. 56 pages. VIA at Roi Et. Presented as panel discussion to 23rd annual scientific meeting of Faculty of Medicine, Khon Kaen University. October 16th - 19th, 2007. Khon Kaen. Sanghvi H, Khunying Limpaphayom K, Plotkin M, Charurat, Kleine A, Lu E, Eamratsameekool W, Palanuwong B. Cervical cancer screening using visual inspection with acetic acid: operational experiences from Ghana and Thailand. Reproductive Health Matter 2008; 16(32):67-77. Practice of VIA and Cryotherapy in a single visit approach (SVA). Symposium on Innovation of Cervical Cancer in low resource setting. Presented to 12th Biennial Meeting of The International Gynecologic Oncology Society, Bangkok, Thailand. October 25th - 28th 2008. Hongsranagon P, Pongpanich S, Eamratsameekool W, Havanond P, Deelertyuenyong N. How ready are distance education learners at Chulalongkorn University? An oral presentation to International e-Learning Conference, 20-21 November 2008; Pathumthani, Thailand. Eamratsameekool W., Hongsaraganon P., Juangphum N., Kokilakanishtha P. Coach-based skill assessment of instructors in distance education. A report of Systematic management of distance learning program. Research report. National Research Council of Thailand. 2009. Presented as 30 minute paper presentation to Sciences in Society Conference, Murray Edward College, Cambridge University. 5-8 August 2009.

STIs and Neoplastic Diseases in lower genital tract HPV and HIV infections: Isabelle Heard
	Isabelle Heard ,Obstetrician and Gynecologist at Hospital Pitie Salpetriere, Paris, France. She has been involved in treating HPV-related cervical disease as a clinician and has been a researcher on the disease for the last 15 years. Her focus has been on infections andneoplasia of the cervix associated with human papillomavirus in HIV-infected women. She received my PhD from the Pasteur Institute.She has a position of Joint-Director at the National Reference Centre for HPV since December 2008.

STIs and Neoplastic Diseases in lower genital tract Treatment of Genital Warts - Efficacy & Limitations
	Christopher Fairley, Australia Melbourne Sexual Health Centre and School of Population Health, University of Melbourne, 580 Swanton Street, Carlton, Victoria 3053.

Proffered Papers III - Cervical Screening and Colposcopy Chairperson
	Vijay Ahuja, Post Doctoral training in Gyn Oncology Tata Memorial Hospital, Mumbai (1986/87), University of Graz, Austria (1993).Current position: Senior Consultant, Gyn Oncology, Dept of Ob-Gyn, Women's Hospital, Hamad Medical Corporation, Doha, Qatar. Past experience: Faculty dept of Gyn Oncology, Kidwai Memorial institute of Oncology, Bangalore, 1984-1996.
Consultant Gyn Oncologist, Bangalore Institute of Oncology, Bangalore 1996-2004 Consultant and Chief of Gyn Oncology Unit, African Oncology Institute, Libya. 2004-2007 Consultant Gyn Oncologist, Dept of Surgical Oncology, Manipal Comprehensive Cancer Center, Bangalore. 2007-2009. Association Membership been on executive committee of Indian society of Oncology, Association of Gyn Oncologists of India and FOGSI committee on Oncology.

Late Breaker Presentations Chairperson
	Vanita Suri Professor Department of obstetrics & Gynecology Published more than 70 papers in national and international journals Honorary secretary north zone FOGSI
Areas of interest: Oncology Colposcopy Assisted reproductive technologies High risk pregnancy

Proffered Papers IV - Advocacy and Education Chairperson
	Dr. Scott Wittet has over 20 years experience in health advocacy and behavior change communications in the developing world. Currently the lead for Advocacy and Communication for PATH's Cervical Cancer Prevention Programs (supported by the Bill & Melinda Gates Foundation), Mr. Wittet's work focuses on building the political, financial, and technical foundations for future introduction of HPV vaccine and new pre-cancer screening technologies in resource-poor settings. From 1998 to 2006, Mr. Wittet held a similar position with PATH's Children's Vaccine Program.
His long history in the field includes many years working with public sector organizations to develop and test effective educational and behavior change strategies for health consumers, health staff and national decision-makers. Mr. Wittet is Chair of the Cervical Cancer Action coalition and works in close collaboration with colleagues at the World Health Organization (WHO), UNFPA, UNICEF, the GAVI Alliance and other international stakeholders concerned with improving immunization and women's health.

Plenary session - Implementation of HPV Vaccination Chairperson
	Prof. Maqsood Siddiqi Prof. Siddiqi has been the Director of two major research centres in India namely the Chittaranjan National Cancer Institute (CNCI) and Bose Institute, Kolkata, India for over 10 years (1994 - 2005) where he guided research and managed a large number of research projects in diverse areas such as preventive cancer research, epidemiology, cancer registration, life-style risk factors and many other other topics in medical research. His discovery of Caffeine-derived N-nitroso compounds and their implication in high incidence of cancer Esophagus and Stomach in Kashmir has received international acclaim.
Besides his many research publications in peer reviewed international journals and books with high citation rating, he is a co-editor of a book "Protective Effects of Tea on Human Health" CABI International, London, UK, 2006 and a recent publication on HPV vaccine entitled 'HPV Infection and its prevention', 2010. He is the founder of Cancer Foundation of India (CFI), a knowledge-based organisation generating information on Preventive aspects of human cancers for the benefit of promoting Cancer Public Health in the country. Prof. Siddiqi has been a Member of a large number of professional organizations and committees in Cancer Research and Control in addition to the membership of several policy-making, regulatory and advisory committees in field of medical science, cancer and health care in India and abroad. The honours and awards conferred on him for his work in Cancer prevention and control, include the Life time Achievement Award in the field of Oncology by the Prime Minister of India in 2000 and the prestigious Kamal Kumari National Award for "Science & Technology" in 2OO7.

Plenary session - Implementation of HPV Vaccination Lessons from vaccine introduction in the developed world (Scotland)
	Heather Cubie, UK,

Plenary session - Implementation of HPV Vaccination Lessons from vaccine introduction in developing countries (India, Vietnam).
	Aisha Jumaan is the Director for our HPV Vaccines: Evidence for Impact project. Dr. Jumaan has over 20 years of in-depth experience and expertise in viral and other vaccine preventable diseases, cervical and breast cancer research, and surveillance. Since 1995, she has been with the US Centers for Disease Control and Prevention. Most recently, she has served as team leader, for Herpes Viruses activities, specifically the varicella and zoster vaccination program within the National Center for Immunization and Respiratory Diseases. Her work has included both research and policy development responsibilities.
Previous team lead and senior epidemiologist positions within CDC have been with the National Immunization Program, the Division of Cancer Control and Prevention, the Nutrition Division, and the Agency for Toxic Substances and Disease Registry. She has also held the position of assistant professor at the Rollins School of Public Health, Epidemiology Department at Emory University.Author and co-author of a number of peer-reviewed publications, Aisha earned her doctorate in epidemiology at the University of North Carolina, Chapel Hill; an MPH degree, also in epidemiology, from Emory University, Atlanta; and her undergraduate degree in biology from Mills College, Oakland, California. In addition, she holds a certificate for Women in Development from the Royal Tropical Institute, the Netherlands. She is fluent in both Arabic and English.

Plenary session - Implementation of HPV Vaccination New tools for comprehensive cervical cancer prevention planning

Prof. Jack Cuzick is head of the Centre for Epidemiology, Mathematics and Statistics at Cancer Research UK in London. He is also John Snow Professor of Epidemiology at Wolfson Institute of Preventive Medicine at Queen Mary, University of London. He holds a PhD in Mathematics and has previously worked at Oxford University and Columbia University, New York. His current interests are in cancer epidemiology and clinical trials, with special interest in prevention and screening. He is currently Chairman of the International Breast Cancer Intervention Study (IBIS) Steering Group, the Independent Statistician for the ATAC trial and is also involved in studies on the use of HPV assays for cervical screening, the use of flexible sigmoidoscopy for colorectal cancer screening and markers for the behaviour of early prostate cancer. He is the statistician for several major breast cancer trials and maintains an active interest in developing new statistical methodology, especially in the area of adjustments for non-compliance and cross-over, and multi-arm clinical trials. He is currently the President of the International Society of Cancer Prevention and is a Fellow of the Academy of Medical Sciences, the Royal Statistical Society, and the Institute of Mathematical Statistics. In 2007, he was chosen by Thompson Scientific as one of the twelve hottest researchers in all of science. He is the author of more than 350 peer-reviewed papers and has published in all the major medical journals.

Plenary session - Implementation of HPV Vaccination HPV Screening- New data & new algorithms

Dr. Attila T. Lorincz is a molecular biologist recognized for his research in human diagnostics and the natural history of human papillomavirus (HPV) infections. Currently he is Professor of Molecular Epidemiology at the Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, England.Prof. Lorincz received a PhD in genetics from Trinity College, Dublin, Ireland in 1980. He conducted post-doctoral research in the molecular biology of the cell cycle at the University of California, San Diego and Santa Barbara from which a key discovery was the cloning and characterization of cdc28, the first cdk gene (Lorincz AT and Reed SI 1984. Nature 307:183). His work on HPV began as a collaboration with the Nobel Laureate Prof. Harald zurHausen and was initiated by an agreement between Georgetown University, Washington DC; DKFZ in Heidelberg Germany; and Bethesda Research Laboratories Inc. (the precursor of Life Technologies Inc.) in 1983. In the years leading up to 1990 he cloned and characterized several clinically important HPV types, provided a clearer understanding of the natural history of HPV infection and pioneered large clinical studies that revealed key evidence of the association of HPV with cervical cancer. In 1990 Dr Lorincz co-founded Digene Corporation (now QIAGEN Corp.) and transfered all the HPV IP and technology from Life Technologies to a new R&D team where he assumed the post of Sr. Vice President R&D until 2006. His work on a non-radioactive assay for HPV culminated in the US FDA approval of the Hybrid Capture (HC) series of HPV tests. These nucleic acid amplification tests are generally recognized as the gold standard in routine HPV screening worldwide, with 10+ million tests conducted annually. More than 40 U.S. and international patents concerning novel HPV types and novel assay systems have been awarded for Prof. Lorincz's work. He has authored 210 original peer-reviewed research papers and books on diverse topics in epidemiology and the basic molecular mechanisms of carcinogenesis. He was primary author of a paper chosen by the American College of Obstetrics and Gynecology as a "classic," the first to show key quantitative differences in the relative risks of HPV types that led to the low, medium, and high risk classification system of HPV cancer risk. The paper is the most frequently cited article to appear in the journal Obstetrics & Gynecology to date.Prof. Lorincz was the recipient of the 1994 AVDA achievement award from the American Venereal Disease Association for outstanding contributions to the field of STD research. In 2000 he received the High Technology Council Prize from the State of Maryland for the development of the HC2 HPV test.His current research interests focus on the interplay between genetics and epigenetics in the development and evolution of prostate, breast, and cervical cancers.

Plenary Session - AOGIN Education Session Chairperson
	You Lin Qiao is a cancer epidemiologist with a special interest in cancer prevention and control of upper GI and cervical cancers in developing countries. Graduating from Johns Hopkins University School of Public Health, he became Director, Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, then director of International Collaboration, Cancer Foundation of China.